Hyser C L, Doherty R A, Griggs R C, Mendell J R, Polakowska R, Quirk S, Brooke M H, Fenichel G M
Neurology. 1987 Sep;37(9):1476-80. doi: 10.1212/wnl.37.9.1476.
DNA studies (restriction fragment length polymorphism linkage analysis and deletion analysis with pERT87) and serum creatine kinase/pyruvate kinase (CK/PK) measurements were done to determine the carrier status of 59 mothers and sisters of isolated Duchenne dystrophy (DD) cases. The results of DNA studies modified the carrier risks for 34 of the 59 (58%), but the derived risks often did not differ importantly from risks calculated by conventional methods. Elevated CK/PK provided strong evidence of the carrier state for 24 of the 59 (41%), and CK/PK frequently provided data unavailable through DNA studies. Serum enzyme determinations remain an important means of evaluating DD carrier suspects and are especially valuable in isolated-case families. Enzyme testing should be combined with DNA studies to achieve the best estimate of carrier risk.
进行了DNA研究(限制性片段长度多态性连锁分析以及使用pERT87进行缺失分析)和血清肌酸激酶/丙酮酸激酶(CK/PK)测量,以确定59例孤立性杜氏肌营养不良症(DD)病例的母亲和姐妹的携带者状态。DNA研究结果改变了59人中34人(58%)的携带者风险,但得出的风险通常与通过传统方法计算出的风险没有显著差异。CK/PK升高为59人中的24人(41%)提供了携带者状态的有力证据,并且CK/PK常常提供通过DNA研究无法获得的数据。血清酶测定仍然是评估DD携带者疑似者的重要手段,在孤立病例家庭中尤其有价值。酶检测应与DNA研究相结合,以实现对携带者风险的最佳估计。